Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

33.6K
Overview
33.6K
Conjugated Proteins02:50

Conjugated Proteins

29.5K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.5K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Vaccinations01:51

Vaccinations

52.8K
Overview
52.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming dendritic cells to overcome tumor-mediated immune suppression.

Frontiers in immunology·2026
Same author

MOG-Peptide Synergizes With Rapamycin to Drive CD4<sup>+</sup> T Cells Into Protective Antigen-Specific Tregs in EAE.

Immunology·2026
Same author

Morphine disrupts antigen-presenting cell function through TLR-4 and autophagy pathways.

Molecular biology reports·2026
Same author

Mental health strain due to COVID-19: Psychological distress and somatic symptoms among health care workers and the general population in Kashmir, India.

Virus research·2026
Same author

Morphine Dependence Vaccines: Advances, Challenges, and Future Directions.

Current pharmaceutical biotechnology·2026
Same author

Lactobacillus plantarum as a Novel Modulator of Immune and Behavioral Recovery in Substance Use Disorders: A Hypothesis.

Current drug research reviews·2026
Same journal

Corrigendum to: Reviewing the Context of Molecular Modeling to Enhance the Application of Machine Learning Technologies for Safer Bioinformatics.

Protein and peptide letters·2026
Same journal

Corrigendum to: A Preliminary Study on the Antibacterial Activity of the Secretion of the Levantine Water Frog, <i>Pelophylax bedriagae</i> (Camerano, 1882) (Anura:Ranidae).

Protein and peptide letters·2026
Same journal

Potent Antioxidant and Antibacterial Activities of ≤3 kDa Hydrolyzed Sarcoplasmic Proteins from IPB-D1 Chicken.

Protein and peptide letters·2026
Same journal

Hybrid 3D Bioprinted Scaffolds for the Delivery of Peptide Therapeutics.

Protein and peptide letters·2026
Same journal

Targeting α-Synuclein: Current Strategies and Emerging Therapies for Synucleinopathies.

Protein and peptide letters·2026
Same journal

Biocompatible Excipients from Microalgae: Advancing Protein and Peptide Therapeutics through Sustainable Formulation Strategies.

Protein and peptide letters·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

8.4K

Immunity in Harmony: Utilizing Overlapping Epitopes for Tuberculosis and COVID-19 Protection.

Kritika Pasricha1, Shivank Prajapati1, Taruna Lamba1

  • 1Immunology Laboratory, Department of Biomedical Engineering, Indian Institute of Technology Ropar, Rupnagar- 140001, India.

Protein and Peptide Letters
|March 5, 2026
PubMed
Summary
This summary is machine-generated.

The Bacillus Calmette-Guérin (BCG) vaccine may offer cross-protection against SARS-CoV-2 by sharing common epitopes with Mycobacteria. This suggests a potential strategy for developing broader vaccines against emerging infectious diseases.

Keywords:
BCGCOVID-19Mycobacterium tuberculosisSARS-CoV-2immunoinformaticsnon-tuberculous mycobacteriavaccines

More Related Videos

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.7K

Related Experiment Videos

Last Updated: Mar 7, 2026

Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

8.4K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.7K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Disease Research

Background:

  • The Bacillus Calmette-Guérin (BCG) vaccine, used for tuberculosis (TB), is associated with reduced incidence of other infections, including viral respiratory illnesses.
  • BCG vaccination has been linked to lower COVID-19 rates in TB-endemic regions, suggesting potential cross-protective immunity.

Purpose of the Study:

  • To investigate shared epitopes between Mycobacteria and SARS-CoV-2 using immunoinformatics.
  • To evaluate the immunogenicity of identified shared epitopes.

Main Methods:

  • Bioinformatic analysis to identify overlapping CD4, CD8, and B-cell epitopes between Mycobacteria and SARS-CoV-2.
  • Synthesis and experimental validation of the most immunodominant T-cell epitope.
  • Assessment of T-cell proliferation and inflammatory molecule expression.

Main Results:

  • Identification of multiple overlapping T-cell and B-cell epitopes between Mycobacteria and SARS-CoV-2.
  • Demonstrated promiscuous binding, high immunogenicity, and strong affinity of T-cell epitopes for HLA alleles.
  • Experimental validation confirmed the ability of a key T-cell epitope to induce T-cell proliferation in COVID-19-vaccinated individuals.

Conclusions:

  • Shared epitopes between Mycobacteria and SARS-CoV-2 may confer broader protection than virus-specific antigens alone.
  • This cross-reactivity could explain enhanced immunity in BCG-vaccinated populations during pandemics.
  • The identified epitopes represent a promising strategy for developing novel vaccines against emerging pathogens.